Ausgabe 6/2017
Inhalt (12 Artikel)
Treating Disease Mechanisms in Patients With Heart Failure and Diabetes Mellitus
Amanda Trang, David Aguilar
MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential
Palak Shah, Michael R. Bristow, J. David Port
Prevention and Treatment of Thrombotic and Hemorrhagic Complications in Patients Supported by Continuous-Flow Left Ventricular Assist Devices
Renzo Y. Loyaga-Rendon, Milena Jani, David Fermin, Jennifer K. McDermott, Diane Vancamp, Sangjin Lee
Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart Failure
Anett H. Ottesen, Geir Christensen, Torbjørn Omland, Helge Røsjø
Skeletal muscle alterations in HFrEF vs. HFpEF
Volker Adams, Axel Linke, Ephraim Winzer
Defining Ambulatory Advanced Heart Failure: MedaMACS and Beyond
Garrick C. Stewart, Amrut V. Ambardekar, Michelle M. Kittleson
Pulmonary Hypertension Due to Left Ventricular Cardiomyopathy: Is it the Result or Cause of Disease Progression?
Srinath Adusumalli, Jeremy A. Mazurek
High-Risk Percutaneous Coronary Intervention in Public Reporting States: the Evidence, Exclusion of Critically Ill Patients, and Implications
Rishi K. Wadhera, Jordan D. Anderson, Robert W. Yeh
Visceral Congestion in Heart Failure: Right Ventricular Dysfunction, Splanchnic Hemodynamics, and the Intestinal Microenvironment
Vincenzo B. Polsinelli, Arjun Sinha, Sanjiv J. Shah
Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure
Kishan S. Parikh, Jonathan P. Piccini
Pharmacogenomics of the Natriuretic Peptide System in Heart Failure
Ahmed Abuzaanona, David Lanfear
Clinical Application of Genetic Testing in Heart Failure
Ana Morales, Ray Hershberger